Kabra Drugs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kabra Drugs Ltd. on BSE

Load latest

Kabra Drugs Ltd.

19 Sep 2024

19.06

2.25%

SAST

KABRA DRUGS LTD. - 524322 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kuniamuthur Nanjappan Anand

pdf

Kabra Drugs Ltd.

09 Sep 2024, 11:14PM

19.06

2.25%

Corp. Note

KABRA DRUGS LTD. - 524322 - Reg. 34 (1) Annual Report.

BSE India

With reference to the captioned subject and pursuant to Reg.34 of the SEBI (Listing and Disclosure Requirements) Regulations, we are submitting we enclose herewith Notice of the 35th Annual General Meeting of the Company to be convened on 30th September, 2024, at 10:00 AM at 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh - 452011.

pdf

Kabra Drugs Ltd.

04 Sep 2024

19.06

2.25%

AGM

KABRA DRUGS LTD. - 524322 - Submission Of Notice Of Annual General Meeting Under Regulation 30 …

BSE India

Notice of 35th Annual General Meeting

pdf

Kabra Drugs Ltd.

03 Sep 2024

19.06

2.25%

Company Update

KABRA DRUGS LTD. - 524322 - Appointment Of Internal Auditor Of The Company

BSE India

Appointment of Internal Auditor

pdf

Kabra Drugs Ltd.

02 Sep 2024

19.06

2.25%

Corp. Action

KABRA DRUGS LTD. - 524322 - Announcement Of Dates For Book Closure And The Schedule Of …

BSE India

Book Closure and Schedule of Events for e-voting.

pdf

Kabra Drugs Ltd.

02 Sep 2024

19.06

2.25%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Board of Directors of the company was held today viz Monday, 2nd September 2024 at registered office at 5:00 P.M. and concluded at 8:00 P.M.

pdf

Kabra Drugs Ltd.

27 Aug 2024

19.06

2.25%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, September 2nd, 2024 at 5:00 PM to consider and approve

pdf

Kabra Drugs Ltd.

14 Aug 2024

19.06

2.25%

Company Update

KABRA DRUGS LTD. - 524322 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2025,

pdf

Kabra Drugs Ltd.

14 Aug 2024

19.06

2.25%

Result

KABRA DRUGS LTD. - 524322 - Financial Results For The Quarter Ended June 30, 2024 Under …

BSE India

Un Audited Financial Result for the Quarter ended June 30, 2024 under Regulation 33 of SEBI (LODR) Regulations, 2015

pdf

Kabra Drugs Ltd.

14 Aug 2024

19.06

2.25%

Board Meeting

KABRA DRUGS LTD. - 524322 - Board Meeting Outcome for Outcome Of The Board Meeting And …

BSE India

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e 14th August 2024,

pdf

Is Kabra Drugs Ltd. worth buying?

4 Votes:

Buy 50.0%

Sell 25.0%

Hold 25.0%

108.53% Gain from 52W Low

High volume today

Kabra Drugs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kabra Drugs Ltd. on BSE